Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 6.32
+0.38 (6.40%)
Aug 6, 2026, 5:35 PM CET
Carvolix Market Cap
Carvolix has a market cap or net worth of €351.91 million as of August 6, 2026. Its market cap has increased by 609.79% in one year.
Market Cap
351.91M
Enterprise Value
369.98M
Revenue
900.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.32
ChartMarket Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 351.91M, an increase of 142.18%. That is a compound annual growth rate of 18.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 351.91M | 416.96% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 212.44M |
| Median Technologies | 155.52M |
| Guerbet | 100.92M |
| Theraclion | 46.13M |
| Novacyt | 30.96M |
| Mauna Kea Technologies | 29.89M |
| Diagnostic Medical Systems | 28.38M |
| Implanet | 25.02M |